Cline submits international patent application for StemCART therapy product
Cline Scientific (Spotlight Stock Market: CLINE B) today announces it has submitted an international PCT patent application covering methods related to the StemCART cartilage therapy project.
This application is an extension to the patent application submitted to the European Patent Authority announced on the 28th of March 2020.
“Our unique method and product have the potential to provide much-needed treatment to patients across the world. This is a vital step in fulfilling Cline’s strategy to gain strong protection for our groundbreaking stem-cell methods using our surface technology.” Says Patrik Sundh, CEO.
After the PCT phase, the patent will enter into national phases where Cline will designate the countries that Cline will pursue patents.
More about the PCT process
The PCT is an international treaty with more than 150 Contracting States, allowing applicants to file for protection in many countries simultaneously with the same filing date. A PCT, or international, the application is a unified patent procedure where an application is filed with a Receiving Office, where an international search report and patentability opinion is then conducted. The PCT does not lead to a patent in itself; it is followed by designating which countries the application wants the patent to be examined. In this "national" phase, each jurisdiction designated assesses the applications and grants the patent.
For more information, please contact:
Patrik Sundh, CEO
Email: patrik.sundh@clinescientific.com
Phone: +46 703-585 088
Cline Scientific AB (publ) Phone: 031-387 55 55
Argongatan 2 C Email: info@clinescientific.com
431 53 MÖLNDAL Website: www.clinescientific.com
About Cline Scientific
Cline Scientific develops advanced cancer diagnostics and regenerative medicine treatments. The company is working heavily with R&D through joint collaborations with pharmaceutical companies and academic researchers around the world. The focus is on projects in the cancer diagnostic and stem cell therapy fields since Clines nanotechnology here provides unmet solutions to critical challenges and functions. The unique patented surface nanotechnology is used in cell-based products and processes to drive projects within Life Science into and through the clinical phase